Which agent is used as a first-line pharmacologic therapy to reduce portal venous pressure during active variceal bleeding?

Which agent is used as a first-line pharmacologic therapy to reduce portal venous pressure during active variceal bleeding?

• A. Octreotide
• B. Vasopressin
• C. Propranolol
• D. Nitroglycerin

Answer: (A)

During active variceal bleeding, the goal is to rapidly lower portal venous inflow to decrease pressure on the varices. Octreotide, a somatostatin analogue, does this effectively by constricting the splanchnic (visceral) vessels, which reduces portal venous blood flow and lowers portal pressure. This quick, targeted effect helps control the bleed and is well tolerated, making it the preferred first-line pharmacologic therapy in this setting. Vasopressin can also lower portal pressure through widespread vasoconstriction, but it carries a higher risk of ischemic complications and often requires coadministration with nitroglycerin to mitigate those risks, which makes it less desirable as the initial single agent. Propranolol is useful for long-term prevention of rebleeding by lowering portal pressure chronically but does not act quickly enough to manage an acute bleed. Nitroglycerin alone doesn't address portal pressure and can worsen hypotension, so it isn’t used as first-line therapy in the acute phase.

During active variceal bleeding, the goal is to rapidly lower portal venous inflow to decrease pressure on the varices. Octreotide, a somatostatin analogue, does this effectively by constricting the splanchnic (visceral) vessels, which reduces portal venous blood flow and lowers portal pressure. This quick, targeted effect helps control the bleed and is well tolerated, making it the preferred first-line pharmacologic therapy in this setting.

Vasopressin can also lower portal pressure through widespread vasoconstriction, but it carries a higher risk of ischemic complications and often requires coadministration with nitroglycerin to mitigate those risks, which makes it less desirable as the initial single agent. Propranolol is useful for long-term prevention of rebleeding by lowering portal pressure chronically but does not act quickly enough to manage an acute bleed. Nitroglycerin alone doesn't address portal pressure and can worsen hypotension, so it isn’t used as first-line therapy in the acute phase.